Healthcare provider profile · identity verified

Anthony James Mazza, M.D.

Family Practice · PORT MATILDA, PA · NPI 1740570142

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	603	180
Lisinopril	Lisinopril	361	98
Omeprazole	Omeprazole	333	94
Gabapentin	Gabapentin	277	66
Amlodipine Besylate	Amlodipine Besylate	217	64
Levothyroxine Sodium	Levothyroxine Sodium	214	63
Losartan Potassium	Losartan Potassium	201	57
Metformin Hcl	Metformin Hcl	195	52
Pantoprazole Sodium	Pantoprazole Sodium	193	58
Tramadol Hcl	Tramadol Hcl	193	39
Rosuvastatin Calcium	Rosuvastatin Calcium	188	53
Hydrochlorothiazide	Hydrochlorothiazide	178	48
Metoprolol Succinate	Metoprolol Succinate	178	59
Tamsulosin Hcl	Tamsulosin Hcl	165	49
Lorazepam	Lorazepam	152	41
Albuterol Sulfate Hfa	Albuterol Sulfate	135	46
Metformin Hcl Er	Metformin Hcl	128	37
Metoprolol Tartrate	Metoprolol Tartrate	121	30
Allopurinol	Allopurinol	115	33
Furosemide	Furosemide	114	38
Oxycodone Hcl	Oxycodone Hcl	104	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	103	19
Montelukast Sodium	Montelukast Sodium	103	32
Eliquis	Apixaban	96	24
Duloxetine Hcl	Duloxetine Hcl	94	21
Jardiance	Empagliflozin	94	22
Prednisone	Prednisone	92	53
Alprazolam	Alprazolam	89	14
Ondansetron Hcl	Ondansetron Hcl	86	18
Ozempic	Semaglutide	86	18
Potassium Chloride	Potassium Chloride	82	24
Meloxicam	Meloxicam	80	22
Fluticasone Propionate	Fluticasone Propionate	79	28
Zolpidem Tartrate	Zolpidem Tartrate	78	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	22
Alendronate Sodium	Alendronate Sodium	71	19
Sertraline Hcl	Sertraline Hcl	71	24
Trazodone Hcl	Trazodone Hcl	71	24
Baclofen	Baclofen	70	12
Trulicity	Dulaglutide	70	11
Finasteride	Finasteride	69	26
Ezetimibe	Ezetimibe	65	16
Celecoxib	Celecoxib	63	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	61	19
Warfarin Sodium	Warfarin Sodium	61	12
Atenolol	Atenolol	58	16
Pravastatin Sodium	Pravastatin Sodium	58	17
Bupropion Xl	Bupropion Hcl	57	19
Clonazepam	Clonazepam	57	suppressed
Pregabalin	Pregabalin	56	suppressed
Simvastatin	Simvastatin	56	16
Clopidogrel	Clopidogrel Bisulfate	55	16
Meclizine Hcl	Meclizine Hcl	52	16
Hydroxyzine Hcl	Hydroxyzine Hcl	48	15
Escitalopram Oxalate	Escitalopram Oxalate	45	17
Ropinirole Hcl	Ropinirole Hcl	45	11
Carvedilol	Carvedilol	43	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	41	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	41	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	30
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	suppressed
Methocarbamol	Methocarbamol	39	14
Spironolactone	Spironolactone	39	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Famotidine	Famotidine	37	13
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Propranolol Hcl	Propranolol Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Sucralfate	Sucralfate	34	14
Synthroid	Levothyroxine Sodium	34	11
Cephalexin	Cephalexin	33	28
Doxycycline Hyclate	Doxycycline Hyclate	33	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Tradjenta	Linagliptin	32	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	11
Glipizide	Glipizide	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Valacyclovir	Valacyclovir Hcl	29	11
Azithromycin	Azithromycin	28	24
Mupirocin	Mupirocin	27	22
Topiramate	Topiramate	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	12
Triamcinolone Acetonide	Triamcinolone Acetonide	24	14
Xarelto	Rivaroxaban	24	suppressed
Doxepin Hcl	Doxepin Hcl	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Novolog Flexpen	Insulin Aspart	22	suppressed
Nystatin	Nystatin	22	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Methadone Hcl	Methadone Hcl	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Ramelteon	Ramelteon	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	19	11
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Cilostazol	Cilostazol	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Felodipine Er	Felodipine	17	suppressed
Klor-Con M10	Potassium Chloride	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clarithromycin	Clarithromycin	15	14
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Fluconazole	Fluconazole	15	11
Fluvoxamine Maleate	Fluvoxamine Maleate	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methenamine Hippurate	Methenamine Hippurate	14	suppressed
Methylphenidate Er	Methylphenidate Hcl	14	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	14	14
Xultophy 100-3.6	Insulin Degludec/Liraglutide	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Levetiracetam	Levetiracetam	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Lactulose	Lactulose	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naproxen	Naproxen	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error